Archive - MoneyMuscle: Which Stocks to Buy and Why

SG Finserve Q1FY27 Results: PAT up 119%, On-track FY27 Guidance

PAT CAGR of 30-35%. AUM CAGR of 30-35%. Trading at premium valuations after strong Q1 results. Opportunity of upside if longer term guidance is…

Jul 26

Piramal Finance Q1 FY27 Result: PAT up 67%, On-track FY27 Guidance

PAT growth of 50%, AUM growth of 25% in FY27. PIRAMALFIN on track to deliver FY27 guidance after Q1 FY27. Re-rating potential of multiples at current…

Jul 19

Bank of Maharashtra Q1 FY27 Results: PAT up 27%, Steady Guidance for FY27

Solid guidance for FY27 after strong performance in Q1 FY27. Strong execution against FY27 guidance by MAHABANK. Premium valuations for a public sector…

Jul 12

JD Cables FY26 Result: PAT up 44%, Strong Guidance till FY28

Guiding 50-60% revenue growth with stable margins. JD Cables looks cheap on forward valuations. Risk if ambitious growth FY27 not delivered as per…

Jul 5

June 2026

Zelio E-Mobility FY26 Result: PAT up 77%, 75%+ Growth Guidance

Guiding 75-80% structural revenue growth. FY26 delivered ahead of guidance. Zelio looks cheap on forward valuations. Risk if FY27 not delivered as per…

Jun 28

Sugs Lloyd FY26 Results: PAT up 72%, Strong FY27 Guidance

Guiding 100% revenue growth in FY27. FY26-28 revenue CAGR of 80%. Trading at cheap valuations. Issue is not valuations but the quality of growth for…

Jun 21

M&B Engineering FY26 Results: PAT up 20%, Steady FY27 Guidance

Guiding 25% revenue growth in FY27. Uncertainty over margins is a risk. Trading at reasonable forward valuation for business promising 25% growth.

Jun 14

Utssav CZ Gold FY26 Results: Profit Up 136%, Strong FY27 Guidance

Utssav Gold guides for 60% revenue growth in FY26 with stable margins after delivering a strong results in FY26. Available at attractive FY27 forward…

Jun 7

Yatharth Hospital FY26 Result: PAT up 30%, Strong FY27 Guidance

Guides for 36%+ revenue CAGR for FY27 with stable margins. Strong outlook of increasing capacity to 5000 beds. Yatharth available at reasonable forward…

Jun 1

May 2026

Sky Gold FY26 Result: Profit Up 102%, Strong Guidance for FY27

Guidance of 35% PAT CAGR for FY26-30. SKYGOLD at attractive forward valuation with potential for re-rating of multiples. Opportunity to ~3x based on…

May 31

Freshara Agro FY26 Results: PAT up 30%, Up to 50% Growth in FY27

Guidance of up to 50% FY27 revenue growth. Even though quality of earnings were weak in terms of cash-flow. Freshara Agro is available at attractive…

May 24

Senores Pharmaceuticals FY26 Results: PAT up 105%, On-track FY26 Guidance

Guiding 50-60% PAT growth in FY27 with 30-40% revenue growth. Revenue CAGR of 25-30% & PAT CAGR of 20-30% for next 3-5 years. At reasonable forward…

May 19

#nojs-banner { position: fixed; bottom: 0; left: 0; padding: 16px 16px 16px 32px; width: 100%; box-sizing: border-box; background: red; color: white; font-family: -apple-system, "Segoe UI", Roboto, Helvetica, Arial, sans-serif, "Apple Color Emoji", "Segoe UI Emoji", "Segoe UI Symbol"; font-size: 13px; line-height: 13px; } #nojs-banner a { color: inherit; text-decoration: underline; } This site requires JavaScript to run correctly. Please turn on JavaScript or unblock scripts